Cargando…
Prediction of esophagogastric varices associated with oxaliplatin administration
BACKGROUND: Oxaliplatin is a key drug for the chemotherapy of colorectal cancer; however, it is also known to cause non‐cirrhotic portal hypertension. We aimed to identify the characteristics of patients who developed esophagogastric varices (EGVs) after treatment with oxaliplatin. METHODS: This stu...
Autores principales: | Satta, Yosuke, Shigefuku, Ryuta, Watanabe, Tsunamasa, Mizukami, Takuro, Tsuda, Takashi, Suzuki, Tatsuya, Ehira, Takuya, Hattori, Nobuhiro, Kiyokawa, Hirofumi, Nakahara, Kazunari, Ikeda, Hiroki, Matsunaga, Kotaro, Takahashi, Hideaki, Matsumoto, Nobuyuki, Okuse, Chiaki, Suzuki, Michihiro, Sunakawa, Yu, Yasuda, Hiroshi, Itoh, Fumio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593783/ https://www.ncbi.nlm.nih.gov/pubmed/34816015 http://dx.doi.org/10.1002/jgh3.12668 |
Ejemplares similares
-
Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function
por: Shigefuku, Ryuta, et al.
Publicado: (2022) -
Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus
por: Ikeda, Hiroki, et al.
Publicado: (2018) -
Risk factors for liver‐related mortality of patients with hepatitis C virus after sustained virologic response to direct‐acting antiviral agents
por: Hattori, Nobuhiro, et al.
Publicado: (2022) -
Curative Effects for B-Cell Lymphoma Accomplished by Direct-Acting Antiviral Agents of Hepatitis C
por: Hattori, Nobuhiro, et al.
Publicado: (2017) -
Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b
por: Matsumoto, Nobuyuki, et al.
Publicado: (2016)